BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
220 results:

  • 1. FDG PET/CT and MRI Findings of Extraskeletal Myxoid Chondrosarcoma Showing a Nonmyxoid Cellular Variant.
    Hirasawa M; Kikuchi Y; Sato K; Yoshida A; Yamamoto A
    Clin Nucl Med; 2024 May; 49(5):434-437. PubMed ID: 38557577
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [
    Trautwein NF; Schwenck J; Seitz C; Seith F; Calderón E; von Beschwitz S; Singer S; Reischl G; Handgretinger R; Schäfer J; Lang P; Pichler BJ; Schulte JH; la Fougère C; Dittmann H
    Theranostics; 2024; 14(3):1212-1223. PubMed ID: 38323317
    [No Abstract]    [Full Text] [Related]  

  • 3. Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor.
    Hamacher R; Pabst KM; Cheung PF; Heilig CE; Hüllein J; Liffers ST; Borchert S; Costa PF; Schaarschmidt BM; Kessler L; Miera MA; Droste M; Akbulut M; Falkenhorst J; Zarrad F; Kostbade K; Mavroeidi IA; Glimm H; Umutlu L; Schuler M; Hübschmann D; Bauer S; Fröhling S; Herrmann K; Siveke JT; Schildhaus HU; Fendler WP
    J Nucl Med; 2024 Feb; 65(2):252-257. PubMed ID: 38176718
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. 68 Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
    Jena SR; Watts A; Aggarwal P; Bachhal V; Kaur H; Dhingra K; Singh H; Bal A; Singh B
    Nucl Med Commun; 2024 Mar; 45(3):229-235. PubMed ID: 38165171
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Guo J; Liao Z; Chen Q; Dong A; Huang M
    Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. First-in-Humans PET Imaging of
    Li X; Ye J; Wang J; Quan Z; Li G; Ma W; Zhang M; Yang W; Wang J; Ma T; Kang F; Wang J
    J Nucl Med; 2023 Dec; 64(12):1880-1888. PubMed ID: 37827842
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development of an automated treatment planning approach for lattice radiation therapy.
    Gaudreault M; Chang D; Kron T; Siva S; Chander S; Hardcastle N; Yeo A
    Med Phys; 2024 Jan; 51(1):682-693. PubMed ID: 37797078
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
    Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
    Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.
    Guo W; Wang X; Lu B; Yu J; Xu M; Huang R; Cheng M; Yang M; Zhao W; Zou C
    Cell Death Dis; 2023 Jul; 14(7):439. PubMed ID: 37460542
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [
    Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
    J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
    Akshintala S; Sundby RT; Bernstein D; Glod JW; Kaplan RN; Yohe ME; Gross AM; Derdak J; Lei H; Pan A; Dombi E; Palacio-Yance I; Herrera KR; Miettinen MM; Chen HX; Steinberg SM; Helman LJ; Mascarenhas L; Widemann BC; Navid F; Shern JF; Heske CM
    Clin Cancer Res; 2023 Sep; 29(17):3329-3339. PubMed ID: 37398992
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
    Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
    J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft.
    Zuco V; Pasquali S; Tortoreto M; Percio S; Doldi V; Barisella M; Collini P; Dagrada GP; Brich S; Gasparini P; Fiore M; Casanova M; Frezza AM; Gronchi A; Stacchiotti S; Ferrari A; Zaffaroni N
    Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37158111
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma.
    Laughlin BS; Golafshar M; Prince M; Liu W; Kutyreff CJ; Ahmed SK; Vern Gross TZ; Haddock M; Petersen I; DeWees TA; Ashman JB
    Acta Oncol; 2023 May; 62(5):473-479. PubMed ID: 37154167
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Gas/phototheranostic Nanocomposite Integrates NIR-II-Peak Absorbing Aza-BODIPY with Thermal-Sensitive Nitric Oxide Donor for Atraumatic Osteosarcoma Therapy.
    Fang Z; Zhang J; Shi Z; Wang L; Liu Y; Wang J; Jiang J; Yang D; Bai H; Peng B; Wang H; Huang X; Li J; Li L; Huang W
    Adv Mater; 2023 Sep; 35(35):e2301901. PubMed ID: 37079477
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cosmetic Filler and PET Positivity: The Risk of a False Positive.
    Eitan DN; Grunebaum LD; Howard BE
    Laryngoscope; 2023 Nov; 133(11):2951-2953. PubMed ID: 36942944
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; Welbon C; James CD; Morgan IM; Spanos WC; Pyeon D
    PLoS Pathog; 2023 Mar; 19(3):e1011171. PubMed ID: 36867660
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
    Guo Z; Liu W; Dong Z; Yang L; Xie P
    Clin Nucl Med; 2023 May; 48(5):435-436. PubMed ID: 36800240
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides.
    Subrahmanyam N; Yathavan B; Yu SM; Ghandehari H
    Mol Pharm; 2023 Mar; 20(3):1670-1680. PubMed ID: 36724294
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.